http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006241031-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95eaed79dec59391549e8016815b3a8f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 |
filingDate | 2005-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d3b7a52b9fdbde21ea48f009e05b793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ec3bc8e05689868aba3999a565fff45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00fbafd7e735758078488d59a1cbacba |
publicationDate | 2006-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2006241031-A |
titleOfInvention | Essence dosage form topical skin preparation |
abstract | PROBLEM TO BE SOLVED: To provide an external skin preparation in the form of an essence dosage form having excellent viscosity stability while containing pyrrolidonecarboxylic acid and / or a salt thereof. SOLUTION 1) Carrageenan 0.5 to 2% by mass and 2) Pyrrolidonecarboxylic acid and / or its salt 0.1 to 10% by mass are contained in a skin external preparation. The external preparation for skin is preferably a cosmetic, its viscosity is preferably 10,000 mPascal ยท second or more, and its pH is preferably 7 or less. The dosage form is preferably an essence dosage form. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013203716-A |
priorityDate | 2005-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.